Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial
- Submitting institution
-
Manchester Metropolitan University
- Unit of assessment
- 3 - Allied Health Professions, Dentistry, Nursing and Pharmacy
- Output identifier
- 2497
- Type
- D - Journal article
- DOI
-
10.1016/S2215-0366(18)30184-6
- Title of journal
- The Lancet Psychiatry
- Article number
- -
- First page
- 633
- Volume
- 5
- Issue
- 8
- ISSN
- 2215-0366
- Open access status
- Compliant
- Month of publication
- August
- Year of publication
- 2018
- URL
-
https://doi.org/10.1016/S2215-0366(18)30184-6
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
17
- Research group(s)
-
G - Mental Health
- Citation count
- 29
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author was a primary investigator on the research and
A. made a substantial contribution to the conception and design of the study; and to the organisation of the conduct of the study; to carrying out the study; and to analysis and interpretation of study data.
And B. The author helped draft the output; and critiqued the output for important intellectual content.
- Non-English
- No
- English abstract
- -
